Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's After-Market Session

Author: Benzinga Insights | September 24, 2025 05:06pm

Gainers

  • PepGen (NASDAQ:PEPG) shares increased by 43.8% to $3.84 during Wednesday's after-market session. The market value of their outstanding shares is at $63.9 million.
  • Immuneering (NASDAQ:IMRX) shares increased by 37.59% to $12.7. The market value of their outstanding shares is at $357.0 million.
  • Qualigen Therapeutics (NASDAQ:QLGN) stock increased by 17.14% to $4.85. The market value of their outstanding shares is at $7.0 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 9.49% to $1.73. The market value of their outstanding shares is at $225.0 million.
  • Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 7.72% to $2.51. The market value of their outstanding shares is at $39.0 million.
  • Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 5.59% to $1.51. The company's market cap stands at $45.4 million.

Losers

  • SeaStar Medical Holding (NASDAQ:ICU) shares declined by 49.2% to $0.63 during Wednesday's after-market session. The company's market cap stands at $32.3 million.
  • Lunai Bioworks (NASDAQ:RENB) stock declined by 25.9% to $0.13. The company's market cap stands at $36.8 million.
  • TNF Pharmaceuticals (NASDAQ:TNFA) shares decreased by 9.24% to $4.72. The market value of their outstanding shares is at $6.4 million.
  • Dyadic International (NASDAQ:DYAI) stock decreased by 7.63% to $1.06. The market value of their outstanding shares is at $39.0 million.
  • KalVista Pharmaceuticals (NASDAQ:KALV) shares fell 4.88% to $12.3. The company's market cap stands at $655.4 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock decreased by 4.74% to $6.55. The market value of their outstanding shares is at $64.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: DYAI ICU IMRX JSPR KALV KPTI LIMN PEPG QLGN RENB SXTC TNFA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist